BPH and prostate cancer are completely different conditions — here are the facts
No. Benign Prostatic Hyperplasia (BPH) and prostate cancer are two separate, unrelated conditions. BPH does not turn into cancer, and having BPH does not mean you're more likely to develop prostate cancer. They happen to affect the same gland and become more common with the same risk factor — age — which is where the confusion usually comes from.
BPH is a benign (non-cancerous) enlargement of the prostate that happens naturally with age, most often starting in the gland's inner 'transition zone' around the urethra — which is exactly why it squeezes the urine passage and causes urinary symptoms. Prostate cancer is a distinct disease process that most often begins in the outer 'peripheral zone' of the gland. Different location, different cell behavior, different disease entirely.
The confusion is understandable: both conditions become more common as men age, both occur in the same organ, both can cause similar urinary symptoms (weak stream, frequency, waking at night to urinate), and both can raise PSA on a blood test. None of that means one causes the other.
According to EAU and AUA guidelines, there is no established causal link showing that BPH increases the risk of developing prostate cancer. A larger prostate on its own is not considered a cancer risk factor. The two conditions are tracked and managed independently of one another.
Have questions about your BPH or PSA results? Book a consultation with Dr. Samer Morsy
💬 WhatsApp Dr. MorsyYes, and it's actually common — since both conditions become more likely with age, many men in their 60s and 70s have some degree of BPH and are also within the age range where prostate cancer screening matters. Having one does not cause or predict the other; they're simply both being watched for in the same patient.
No — medications for BPH (alpha-blockers like tamsulosin, or 5-alpha-reductase inhibitors like finasteride) do not cause prostate cancer. In fact, laser enucleation surgery for BPH (HoLEP/ThuLEP) has a built-in safety advantage: because the removed prostate tissue is always sent for pathological examination, an unsuspected early-stage cancer is occasionally discovered and caught early — a benefit that medication-only management or other MIST techniques don't offer in the same way.
Having BPH symptoms doesn't replace cancer screening, and it doesn't exempt you from it either. Standard guidance still applies: a baseline PSA and discussion of screening around age 50 (or 45 with a family history of prostate cancer), a digital rectal exam, and prompt evaluation of any persistently rising or unusually high PSA — regardless of how well-explained your BPH symptoms seem.
BPH and prostate cancer are two different conditions that happen to share the same organ and the same main risk factor — age. One does not become the other, and having BPH doesn't raise your cancer risk. The right approach is to manage BPH symptoms on their own merits, and keep up with independent, guideline-based cancer screening at the same time.
Ready to take the next step? Book your appointment today
📅 Book Appointment